AGT, angiotensinogen, 183

N. diseases: 765; N. variants: 43
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Patients with mild-to-moderate essential hypertension in the HOMED-BP trial were randomly allocated to first-line treatment with a calcium channel blocker (CCB), angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB). 24192120 2013
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 Biomarker disease BEFREE The autoantibodies against angiotensin AT1 receptors (AT1-AAs) in patients with essential hypertension exhibited an agonistic action like angiotensin II and maintained high blood pressure (BP). 24131669 2014
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE The relationship between angiotensinogen gene polymorphisms and essential hypertension in a Northern Han Chinese population. 23716723 2014
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE We determined the association of angiotensinogen (M235T) gene polymorphism with essential hypertension and the relationship between polymorphism in the angiotensinogen (M235T) gene and blood pressure response to ACE inhibitor (Enalapril) in patients with essential hypertension from northern Indian subjects. 22974788 2012
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE High risk for essential hypertension in males conferred by g.15241A>G polymorphism in intron 3 of AGT gene. 22799745 2013
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE The current meta-analysis suggested that AGT A-6G gene polymorphism might not be related to the increased risk of essential hypertension in the entire Chinese population. 22710764 2012
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE We attempted to evaluate the risk of -217G>A, -152G>A, -20A>C, -6G>A, T174M, M235T and 15241A>G polymorphisms at AGT locus along with the analyses of haplotype and epistatic interactions in causing susceptibility to EHT. 22570327 2012
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts. 22407378 2012
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 Biomarker disease BEFREE Our results suggest that the positive association between angiotensinogen gene polymorphisms and haplotypes with essential hypertension is not simply explained by an increase in plasma angiotensinogen concentration. 22371359 2012
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Our study indicated that three polymorphisms (A-6G, A-20C and G-217A) in the AGT gene are associated with essential hypertension in the Chinese population. 22156763 2012
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE We aimed to assess the association of the variants of AGT gene and the extent of risk involved in developing EH. 22148914 2012
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Individuals carrying the mutated TT of AGT, DD of ACE and CC of AT1R genotypes had an 1.67 (P = 0.032), 3.09 (P < 0.001) and 3.45 (P < 0.001)-fold increased risk of HTA. 21779803 2012
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Association between the M268T polymorphism in the angiotensinogen gene and essential hypertension in a South Indian population. 21312059 2011
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 Biomarker disease BEFREE Angiotensin II type 1 genotyping and relative telomere length were investigated by PCR in 40 patients of essential hypertension and 15 healthy controls. 21234654 2011
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE The purpose of the study is to explore the association of a new genetic marker of renin gene, and AGT gene M235T, A-6G, and A-20C polymorphisms and their haplotypes with EH in the Mongolian population. 20662730 2010
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE We performed a meta-analysis with the aim of assessing the association of the angiotensin II type 1 (AT(1)) receptor gene A1166C polymorphism with essential hypertension in Chinese case-control studies. 20223791 2010
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 Biomarker disease BEFREE The angiotensinogen gene has been linked with human essential hypertension in whites but the relationship in Asian populations has been less consistent. 20216084 2010
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE The present meta-analysis suggests that AGT M235T and ACE I/D modulate the risk of essential hypertension in Han Chinese population. 20087216 2010
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 Biomarker disease BEFREE Current pharmacological therapy of essential hypertension focuses on the regulation of vascular resistance by inhibition of hormones such as catecholamines and angiotensin II, blocking them from receptor activation. 20060896 2010
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 Biomarker disease BEFREE SNPs and AGT haplotypes were tested for association with plasma AGT, renal plasma flow (RPF), and essential hypertension. 19770777 2010
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Human angiotensinogen (AGT) gene promoter polymorphisms (G-217A; A-20C; G-6A) influence AGT transcription in vitro and have been implicated in the genetics of essential hypertension. 19536167 2010
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE A case-control study of 538 individuals investigated whether the angiotensinogen gene (AGT) might be implicated in the pathogenesis of essential hypertension in the Hani and Yi populations of China. 19365726 2009
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Therefore, A6G polymorphism of the AGT gene could be a potential genetic marker for increased susceptibility to essential hypertension with or without T2DMin Malaysian subjects. 19243623 2009
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Our results revealed that AGT A-6G, T174 M and ACE-I/D were significantly associated with EH (AGT A-6G: AG+GG vs AA; OR=1.36; 95% CI=1.04-1.77. 18830250 2009
CUI: C0085580
Disease: Essential Hypertension
Essential Hypertension
0.600 GeneticVariation disease BEFREE Renin-angiotensin system gene polymorphisms are associated with essential hypertension; angiotensinogen gene variants are considered potential genetic risk factors. 18475146 2008